Matches in SemOpenAlex for { <https://semopenalex.org/work/W4250485683> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4250485683 abstract "Abstract Background Apathy is a highly challenging factor in the general treatment of patients with Parkinson’s disease (PD) and can present a major burden for caregivers. The objective of this study to answer the question of what is known about the current evidence-based pharmacological treatment of apathy, not combined with comorbid depression or dementia, in PD. Methods We searched for publications in online databases (PubMed, Embase.com, Cochrane Database of Systematic Reviews, CENTRAL and PsycInfo/Ebsco) and performed a review of the literature. Included trials were based on patients with PD, with a drug intervention and apathy as an outcome measurement. Patients with comorbid dementia, severe depression, or patients after deep brain stimulation were excluded. Results Out of 1767 articles, we included 10 articles with a total of 723 patients who received intervention and 311 patients who received placebo, standard care or were healthy controls. Combining the results of the studies with a focus on favourable significant outcomes and the risk of bias, we would advise rivastigmine as a treatment of apathy in patients with PD, and pramipexole or selegiline in PD patients with apathy without cognitive disturbance. An important limitation of this study is that the included studies show a broad heterogeneity. Conclusions Research is sparse on the topic of evidence-based pharmacological treatment for apathy in PD. Combining the results of the studies with a focus on favourable significant outcomes and the risk of bias, we would advise rivastigmine as a treatment of apathy in patients with PD, and pramipexole or selegiline in PD patients with apathy without cognitive disturbance." @default.
- W4250485683 created "2022-05-12" @default.
- W4250485683 creator A5001716590 @default.
- W4250485683 creator A5016359874 @default.
- W4250485683 creator A5031486761 @default.
- W4250485683 creator A5078661071 @default.
- W4250485683 date "2020-01-20" @default.
- W4250485683 modified "2023-09-25" @default.
- W4250485683 title "Pharmacological treatment of apathy in Parkinson’s disease, review of the literature" @default.
- W4250485683 doi "https://doi.org/10.21203/rs.2.21219/v1" @default.
- W4250485683 hasPublicationYear "2020" @default.
- W4250485683 type Work @default.
- W4250485683 citedByCount "0" @default.
- W4250485683 crossrefType "posted-content" @default.
- W4250485683 hasAuthorship W4250485683A5001716590 @default.
- W4250485683 hasAuthorship W4250485683A5016359874 @default.
- W4250485683 hasAuthorship W4250485683A5031486761 @default.
- W4250485683 hasAuthorship W4250485683A5078661071 @default.
- W4250485683 hasBestOaLocation W42504856831 @default.
- W4250485683 hasConcept C118552586 @default.
- W4250485683 hasConcept C126322002 @default.
- W4250485683 hasConcept C139719470 @default.
- W4250485683 hasConcept C162324750 @default.
- W4250485683 hasConcept C168563851 @default.
- W4250485683 hasConcept C169900460 @default.
- W4250485683 hasConcept C2776134090 @default.
- W4250485683 hasConcept C2776332859 @default.
- W4250485683 hasConcept C2776509080 @default.
- W4250485683 hasConcept C2776867660 @default.
- W4250485683 hasConcept C2779134260 @default.
- W4250485683 hasConcept C2779424955 @default.
- W4250485683 hasConcept C2779483572 @default.
- W4250485683 hasConcept C2779734285 @default.
- W4250485683 hasConcept C2779989193 @default.
- W4250485683 hasConcept C2780665704 @default.
- W4250485683 hasConcept C2780733359 @default.
- W4250485683 hasConcept C2780904820 @default.
- W4250485683 hasConcept C2781249495 @default.
- W4250485683 hasConcept C71924100 @default.
- W4250485683 hasConceptScore W4250485683C118552586 @default.
- W4250485683 hasConceptScore W4250485683C126322002 @default.
- W4250485683 hasConceptScore W4250485683C139719470 @default.
- W4250485683 hasConceptScore W4250485683C162324750 @default.
- W4250485683 hasConceptScore W4250485683C168563851 @default.
- W4250485683 hasConceptScore W4250485683C169900460 @default.
- W4250485683 hasConceptScore W4250485683C2776134090 @default.
- W4250485683 hasConceptScore W4250485683C2776332859 @default.
- W4250485683 hasConceptScore W4250485683C2776509080 @default.
- W4250485683 hasConceptScore W4250485683C2776867660 @default.
- W4250485683 hasConceptScore W4250485683C2779134260 @default.
- W4250485683 hasConceptScore W4250485683C2779424955 @default.
- W4250485683 hasConceptScore W4250485683C2779483572 @default.
- W4250485683 hasConceptScore W4250485683C2779734285 @default.
- W4250485683 hasConceptScore W4250485683C2779989193 @default.
- W4250485683 hasConceptScore W4250485683C2780665704 @default.
- W4250485683 hasConceptScore W4250485683C2780733359 @default.
- W4250485683 hasConceptScore W4250485683C2780904820 @default.
- W4250485683 hasConceptScore W4250485683C2781249495 @default.
- W4250485683 hasConceptScore W4250485683C71924100 @default.
- W4250485683 hasLocation W42504856831 @default.
- W4250485683 hasOpenAccess W4250485683 @default.
- W4250485683 hasPrimaryLocation W42504856831 @default.
- W4250485683 hasRelatedWork W13376431 @default.
- W4250485683 hasRelatedWork W15509595 @default.
- W4250485683 hasRelatedWork W20314089 @default.
- W4250485683 hasRelatedWork W20715974 @default.
- W4250485683 hasRelatedWork W5652266 @default.
- W4250485683 hasRelatedWork W5836543 @default.
- W4250485683 hasRelatedWork W6567576 @default.
- W4250485683 hasRelatedWork W754091 @default.
- W4250485683 hasRelatedWork W8142487 @default.
- W4250485683 hasRelatedWork W8572274 @default.
- W4250485683 isParatext "false" @default.
- W4250485683 isRetracted "false" @default.
- W4250485683 workType "article" @default.